Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Hideki Ikeda"'
Autor:
Hideki Ikeda, MD, Joji Nagasaki, MD, PhD, Daiki Shimizu, MD, Yuki Katsuya, MD, PhD, Hidehito Horinouchi, MD, PhD, Yukio Hosomi, MD, PhD, Etsuko Tanji, MS, Takekazu Iwata, MD, PhD, Makiko Itami, MD, PhD, Masahito Kawazu, MD, PhD, Yuichiro Ohe, MD, PhD, Takuji Suzuki, MD, PhD, Yosuke Togashi, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 10, Pp 100573- (2023)
Introduction: Unresectable or recurrent thymic epithelial tumors (TETs) have a poor prognosis, and treatment options are limited. This study aimed to investigate the immunologic significance of CD80/CD86 or major histocompatibility complex class II (
Externí odkaz:
https://doaj.org/article/e22f91bb33b34c45b99ef4b5ba01a266
Autor:
Hideki Ikeda
Publikováno v:
Journal of Diabetes Research, Vol 2022 (2022)
Background. An increase in the levels of branched-chain amino acids (BCAAs) and certain aromatic amino acids, such as alanine, in plasma is correlated with insulin resistance (IR) in type 2 diabetes mellitus (T2DM). T2DM is a leading risk factor for
Externí odkaz:
https://doaj.org/article/825374633de14b1498f44ebe19d6aab0
Autor:
Takuya Matsuzaki, Hajime Kasai, Hideki Ikeda, Yuki Tajiri, Kenichi Suzuki, Akira Watanabe, Katsuhiko Kamei, Takashi Urushibara
Publikováno v:
Respirology Case Reports, Vol 9, Iss 6, Pp n/a-n/a (2021)
Abstract Chrysosporium zonatum is a soil‐dwelling fungus that rarely causes pulmonary infections, and a small number of cases have been reported to date. A 74‐year‐old man, who had previously been treated for tuberculosis, presented with sympto
Externí odkaz:
https://doaj.org/article/e62b039fc13f4e889bb14c6bd3369dd4
Autor:
Shotaro Ide, Shigeki Nakamura, Yoshihiro Yamamoto, Yoshihisa Kohno, Yuichi Fukuda, Hideki Ikeda, Eisuke Sasaki, Katsunori Yanagihara, Yasuhito Higashiyama, Kohji Hashiguchi, Yoji Futsuki, Yuichi Inoue, Kiyoyasu Fukushima, Naofumi Suyama, Shigeru Kohno
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0128304 (2015)
Background and objectivesRecent reports indicate that the incidence of nontuberculous mycobacterial-lung disease (NTM-LD) is increasing. This study aimed to investigate the epidemiology and clinical features of NTM-LD patients in Nagasaki prefecture,
Externí odkaz:
https://doaj.org/article/9c46c28204f34d12bd30296b06525919
Autor:
Fumiaki Mukohara, Kazuma Iwata, Takamasa Ishino, Takashi Inozume, Joji Nagasaki, Youki Ueda, Ken Suzawa, Toshihide Ueno, Hideki Ikeda, Katsushige Kawase, Yuka Saeki, Shusuke Kawashima, Kazuo Yamashita, Yu Kawahara, Yasuhiro Nakamura, Akiko Honobe-Tabuchi, Hiroko Watanabe, Hiromichi Dansako, Tatsuyoshi Kawamura, Yutaka Suzuki
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America; 8/27/2024, Vol. 121 Issue 35, p1-40, 51p
Autor:
Yuki Sato, Hiromitsu Sumikawa, Ryota Shibaki, Takeshi Morimoto, Yoshihiko Sakata, Yuko Oya, Motohiro Tamiya, Hidekazu Suzuki, Hirotaka Matsumoto, Takashi Yokoi, Kazuki Hashimoto, Hiroshi Kobe, Aoi Hino, Megumi Inaba, Yoko Tsukita, Hideki Ikeda, Daisuke Arai, Hirotaka Maruyama, Satoshi Hara, Shinsuke Tsumura, Shinya Sakata, Daichi Fujimoto
Publikováno v:
Chest. 162:1188-1198
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e56f2b744764547b03aa1a48c2530678
https://doi.org/10.1016/j.chest.2022.05.035
https://doi.org/10.1016/j.chest.2022.05.035
Autor:
Issei Tokimatsu, Tetsuya Matsumoto, Hiroki Tsukada, Yuji Fujikura, Makoto Miki, Yoshitomo Morinaga, Junko Sato, Tomotaro Wakamura, Hiroshi Kiyota, Kazuhiro Tateda, Hideji Yanagisawa, Takaaki Sasaki, Hideki Ikeda, Hiroshi Horikawa, Hiroshi Takahashi, Masafumi Seki, Yoshiaki Mori, Hiroaki Takeda, Daisuke Kurai, Naoki Hasegawa, Yoshifumi Uwamino, Makoto Kudo, Masaki Yamamoto, Yuko Nagano, Sakika Nomura, Takafumi Tetsuka, Miyuki Hosokai, Nobuki Aoki, Yoshihiro Yamamoto, Yoshitsugu Iinuma, Hiroshige Mikamo, Hiroyuki Suematsu, Takaya Maruyama, Atsushi Kawabata, Yoshiko Sugaki, Atsushi Nakamura, Yasunori Fujikawa, Tatsuya Fukumori, Akira Ukimura, Hiroshi Kakeya, Makoto Niki, Koichiro Yoshida, Yoshihiro Kobashi, Hirokazu Tokuyasu, Kazuhiro Yatera, Hiroaki Ikegami, Masaki Fujita, Takemasa Matsumoto, Katsunori Yanagihara, Junichi Matsuda, Kazufumi Hiramatsu, Takashi Shinzato
Publikováno v:
Journal of Infection and Chemotherapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e460e5f087a79f58a7dc871aa144e22d
https://doi.org/10.1016/j.jiac.2023.04.008
https://doi.org/10.1016/j.jiac.2023.04.008
Autor:
Hirotaka Matsumoto, Hidekazu Suzuki, Yoko Tsukita, Daisuke Arai, Satoshi Hara, Takeshi Uenami, Motohiro Tamiya, Shinsuke Tsumura, Asuka Okada, Yoshihiko Sakata, Takashi Yokoi, Hideki Ikeda, Megumi Inaba, Yuki Sato, Shinya Sakata, Hirotaka Maruyama, Hiroshi Kobe, Go Saito, Takuro Sakagami, Jun Morinaga, Ryota Shibaki, Yuko Oya
Publikováno v:
European Journal of Cancer. 159:144-153
Osimertinib is the standard of care in the initial treatment for advanced epidermal growth factor receptor (EGFR) mutation-positive lung cancer. However, clinical data and reliable prognostic biomarkers are insufficient.We performed a retrospective m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a83d48a42905d426d98299719b208d6d
https://doi.org/10.1016/j.ejca.2021.09.041
https://doi.org/10.1016/j.ejca.2021.09.041
Autor:
Shunya Shiohira, Toshihiko Sugiura, Hideki Ikeda, Shunichiro Iwasawa, Yuto Akimoto, Hajime Kasai, Kohei Shikano, Aoi Hino, Atsushi Saiga, Jun Koizumi, Yasuo Sekine, Takuji Suzuki
Publikováno v:
American Journal of Case Reports. 24
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c9043b71a644abb9b656d69488063a55
https://doi.org/10.12659/ajcr.938311
https://doi.org/10.12659/ajcr.938311
Autor:
Mihoko Imaji, Daichi Fujimoto, Yuki Sato, Yoshihiko Sakata, Yuko Oya, Motohiro Tamiya, Hidekazu Suzuki, Hideki Ikeda, Takashi Kijima, Hirotaka Matsumoto, Masaki Kanazu, Aoi Hino, Megumi Inaba, Yoko Tsukita, Daisuke Arai, Hirotaka Maruyama, Satoshi Hara, Shinsuke Tsumura, Hiroshi Kobe, Hiromitsu Sumikawa, Shinya Sakata, Nobuyuki Yamamoto
Publikováno v:
European journal of cancer (Oxford, England : 1990). 179
Although osimertinib is a standard first-line treatment for patients with advanced-stage non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations, the incidence rate of pneumonitis associated with osimertinib is high.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cb6d62267acfc2ad564385ba1df3ee0
https://pubmed.ncbi.nlm.nih.gov/36470023
https://pubmed.ncbi.nlm.nih.gov/36470023